133868-67-4

Upstream product

• 133467-03-5 Boc-D-His(N^τ-Boc)-OMe 
• 109013-61-8 (R)-2-Amino-3-(3-benzyl-3H-imidazol-4-yl)-propionic acid; hydrochloride 
• 109013-56-1 (R)-3-(3-Benzyl-3H-imidazol-4-yl)-2-tert-butoxycarbonylamino-propionic acid methyl ester 
• 17674-16-7 benzyl triflate 
• 114786-42-4 (R)-1-Benzyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid; hydrochloride 
• 149-73-5 trimethyl orthoformate 
• 16832-24-9 1-benzyl-L-histidine 
• 67-56-1 methanol 
• 114787-96-1 1-Benzyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid 

Downstream Products

• 1300034-13-2 1-benzyl-1H-imidazo[4,5-c]pyridin-6-carboxylic acid methyl ester 
• 114786-56-0 (R)-1-Benzyl-5-diphenylacetyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid methyl ester 
• 136777-59-8 (R)-1-Benzyl-5-diphenylacetyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid 
• 133868-64-1 (+/-)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1-(phenylmethyl)-1H-imidazo<4.5-c>pyridine-6-carboxylic acid 
• 133868-65-2 (+/-)-4,5,6,7-tetrahydro-1-(phenylmethyl)-5-<(phenylmethyl)sulfonyl>-1H-imidazo<4.5-c>pyridine-6-carboxylic acid 
• 133807-94-0 (+/-)-4,5,6,7-tetrahydro-5-<(methylphenylamino)carbonyl>-1-(phenylmethyl)-1H-imidazo<4.5-c>pyridine-6-carboxylic acid 
• 133808-01-2 (+/-)-4,5,6,7-tetrahydro-5-<(methylphenylamino)carbonyl>-1-(phenylmethyl)-1H-imidazo<4.5-c>pyridine-6-carboxylic acid 
• 133807-92-8 (+/-)-5-acetyl-4,5,6,7-tetrahydro-1-(phenylmethyl)-1H-imidazo<4.5-c>pyridine-6-carboxylic acid 
• 133807-83-7 (+/-)-4,5,6,7-tetrahydro-1-(phenylmethyl)-5-<(phenylmethyl)sulfonyl>-1H-imidazo<4.5-c>pyridine-6-carboxylic acid methyl ester 
• 133807-98-4 (+/-)-4,5,6,7-tetrahydro-1-(phenylmethyl)-1H-imidazo<4.5-c>pyridine-6-carboxamide 
• 114786-15-1 (+/-)-4,5,6,7-tetrahydro-1,5-bis(phenylmethyl)-1H-imidazo<4.5-c>pyridine-6-carboxylic acid methyl ester 
• 114786-56-0 (+/-)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1-(phenylmethyl)-1H-imidazo<4.5-c>pyridine-6-carboxylic acid methyl ester 

Relevant academic research and scientific papers

NOVEL OXIME DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS

The present invention provides new oxime derivatives of the general formula (I), pharmaceutical compositions containing them and their use for the treatment and/or prophylaxis of conditions associated with altered glutamatergic signalling and/or functions

Synthesis and Structure-Activity Relationships of a Novel Series of Non-Peptide Angiotensin II Receptor Binding Inhibitors Specific for the AT2 Subtype

Structure-activity relationships are reported for a novel class of 4,5,6,7-tetrahydro-1H-imidazopyridine-6-carboxylic acid derivatives that displace 125I-labeled angiotensin II from a specific subset of angiotensin II (Ang II) binding sites in rat